Pulmonary Atresia With Intact Septum Survival, Reintervention, and Days in Hospital Through Childhood: Contemporary

Dan-Mihai Dorobantu1,2, Qi Huang3, Ferran Espuny-Pujol3,4

  • 1Children's Health and Exercise Research Centre (CHERC), Medical School, University of Exeter, United Kingdom (D.-M.D.).

Insights

Transcatheter right ventricular decompression is the preferred initial treatment for pulmonary atresia with intact ventricular septum, showing improved outcomes. Biventricular repair offers better long-term survival but requires more reinterventions than single-ventricle palliation.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Surgical Outcomes

Background:

  • Pulmonary atresia with intact ventricular septum (PA/IVS) management has evolved.
  • Increased use of transcatheter right ventricular decompression (RVAD) is noted.
  • Contemporary outcomes following RVAD in PA/IVS patients are largely unknown.

Purpose of the Study:

  • To evaluate contemporary national outcomes in PA/IVS patients aged 0-18 years.
  • To assess the impact of different treatment pathways on mortality, reintervention, and hospital stay.

Main Methods:

  • Retrospective analysis of PA/IVS patients (2000-2022) in England and Wales.
  • Linking national data sets for comprehensive outcome assessment.
  • Stratification by initial intervention: RVAD, stage 1 palliation, or pre-intervention death/loss.

Main Results:

  • 58.8% underwent RVAD (84.8% transcatheter); 32.4% received stage 1 palliation.
  • 54.5% achieved biventricular (BiV) repair; 26.7% underwent single-ventricle palliation.
  • 1-year mortality: 7.7% for RVAD vs. 37.2% for stage 1 palliation. 10-year reintervention: 62.6% post-BiV repair vs. 32.8% post-stage 3 palliation.

Conclusions:

  • Transcatheter RVAD is the predominant initial intervention for PA/IVS, with lower in-hospital mortality than historical series.
  • BiV repair is achievable in over half of patients, offering better long-term survival but higher reintervention rates.
  • Early mortality remains high in severe cases; single-ventricle palliation has lower reintervention but more hospital days.
Abstract

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...